The glucagon-like peptide 1 (GLP-1) market has witnessed robust growth, expanding from $22.06 billion in 2025 to an expected $23.88 billion in 2026, at a compound annual growth rate (CAGR) of 8.2%
Glutathione is known to protect against many diseases and conditions, in part due to its ability to reduce oxidative stress, such as alcoholism, Alzheimers disease, asthma, atherosclerosis, cataracts, chronic fatigue syndrome, colitis, diabetes, glaucoma, heart disease, hepatitis, high cholesterol, liver disease, osteoarthritis, Lyme disease, and Parkinsons disease
The duration of use varies for each individual
Pharmacy involvement begins only after prescribing decisions are finalized